3/12
09:15 am
artl
Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
Low
Report
Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
2/15
09:12 am
artl
Artelo Biosciences to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20th [Yahoo! Finance]
Medium
Report
Artelo Biosciences to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20th [Yahoo! Finance]
2/15
09:00 am
artl
Artelo Biosciences to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20th
Medium
Report
Artelo Biosciences to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20th
1/23
08:37 am
artl
Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12's Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy [Yahoo! Finance]
Low
Report
Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12's Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy [Yahoo! Finance]
1/23
08:30 am
artl
Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy
Medium
Report
Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy
1/8
08:43 am
artl
Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12 [Yahoo! Finance]
Medium
Report
Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12 [Yahoo! Finance]
1/8
08:30 am
artl
Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12
Medium
Report
Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12